JP2015514074A - 局所化学的神経麻痺薬を使用して皺を処置する方法 - Google Patents

局所化学的神経麻痺薬を使用して皺を処置する方法 Download PDF

Info

Publication number
JP2015514074A
JP2015514074A JP2015501926A JP2015501926A JP2015514074A JP 2015514074 A JP2015514074 A JP 2015514074A JP 2015501926 A JP2015501926 A JP 2015501926A JP 2015501926 A JP2015501926 A JP 2015501926A JP 2015514074 A JP2015514074 A JP 2015514074A
Authority
JP
Japan
Prior art keywords
botulinum toxin
positively charged
gly
group
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015501926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514074A5 (enExample
Inventor
ジェイコブ ウォー
ジェイコブ ウォー
エル． ダニエル ブラウン
エル． ダニエル ブラウン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revance Therapeuticals Inc
Original Assignee
Revance Therapeuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revance Therapeuticals Inc filed Critical Revance Therapeuticals Inc
Publication of JP2015514074A publication Critical patent/JP2015514074A/ja
Publication of JP2015514074A5 publication Critical patent/JP2015514074A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Biotechnology (AREA)
JP2015501926A 2012-03-22 2013-03-22 局所化学的神経麻痺薬を使用して皺を処置する方法 Pending JP2015514074A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614206P 2012-03-22 2012-03-22
US61/614,206 2012-03-22
PCT/US2013/033417 WO2013142755A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Publications (2)

Publication Number Publication Date
JP2015514074A true JP2015514074A (ja) 2015-05-18
JP2015514074A5 JP2015514074A5 (enExample) 2016-05-19

Family

ID=49212026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501926A Pending JP2015514074A (ja) 2012-03-22 2013-03-22 局所化学的神経麻痺薬を使用して皺を処置する方法

Country Status (11)

Country Link
US (2) US20130251770A1 (enExample)
EP (2) EP3103472A1 (enExample)
JP (1) JP2015514074A (enExample)
KR (1) KR20140139010A (enExample)
CN (1) CN104602703A (enExample)
AU (1) AU2013234988A1 (enExample)
BR (1) BR112014023244A2 (enExample)
CA (1) CA2867511A1 (enExample)
HK (1) HK1207007A1 (enExample)
MX (1) MX2014011376A (enExample)
WO (1) WO2013142755A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018531984A (ja) * 2015-10-29 2018-11-01 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP3760186A1 (en) * 2014-04-30 2021-01-06 Allergan, Inc. Formulations of biologics for intravesical instillation
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
WO2020069222A1 (en) * 2018-09-26 2020-04-02 Global Health Solutions Llc Topical neurotoxin compositions
KR20200080179A (ko) 2018-12-26 2020-07-06 아미코젠주식회사 아세틸콜린 수용체 저해 펩타이드 및 이의 용도
EP4393502A2 (en) 2018-12-26 2024-07-03 Skinmed Co., Ltd. Acetylcholine receptor inhibitory peptides and uses thereof
KR20230017747A (ko) 2021-07-27 2023-02-06 주식회사 스킨메드 아세틸콜린 수용체 결합 최적화 단축 펩타이드 및 이의 용도
EP4378950A4 (en) 2021-07-27 2025-10-15 Skinmed Co Ltd OPTIMIZED SHORTENED PEPTIDE THAT BINDS TO THE ACETYLCHOLINE RECEPTOR, AND ITS USE

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005306746A (ja) * 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
JP2006528975A (ja) * 2003-05-09 2006-12-28 セフアロン・インコーポレーテツド 経粘膜送達デバイスとともに使用のための溶解可能な裏打ち層
JP2007526340A (ja) * 2004-03-03 2007-09-13 ルバンス セラピュティックス ボツリヌストキシンの局所適用及び経皮送達のための組成物及び方法
JP2007527431A (ja) * 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
JP2007538010A (ja) * 2004-05-07 2007-12-27 ファイトトックス リミテッド フィコトキシンの経皮投与
JP2008531732A (ja) * 2005-03-03 2008-08-14 ルバンス セラピュティックス インク． ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法
JP2010514781A (ja) * 2006-12-29 2010-05-06 ルバンス セラピュティックス インク． Ｈｉｖ−ｔａｔに由来するポリペプチド断片を用いて安定化されるボツリヌス毒素を局所適用及び経皮送達する組成物及び方法
JP2013509248A (ja) * 2009-10-30 2013-03-14 ルバンス セラピュティックス インク． 治療組成物又は美容組成物を局所的に塗布する装置及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5632731A (en) * 1994-11-25 1997-05-27 The Kendall Company Non-adherent wound dressing
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
US7838011B2 (en) 2005-02-14 2010-11-23 Pankaj Modi Stabilized protein compositions for topical administration and methods of making same
WO2007059528A2 (en) 2005-11-17 2007-05-24 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
PL3144013T3 (pl) 2005-12-01 2019-04-30 Univ Of Massachusetts Lowell Nanoemulsje botulinowe
US20100050075A1 (en) 2008-08-22 2010-02-25 Lennox Manufacturing, Inc., A Corporation Of Delaware Display apparatus and method for a control unit for an environmental control system
CN102869373B (zh) 2009-06-25 2017-05-10 雷文斯治疗公司 不含白蛋白的肉毒杆菌毒素制剂
ES3036435T3 (en) * 2011-01-07 2025-09-18 Revance Therapeutics Inc Kits for topical application, removal, and inactivation of therapeutic or cosmetic botulinum toxin compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006528975A (ja) * 2003-05-09 2006-12-28 セフアロン・インコーポレーテツド 経粘膜送達デバイスとともに使用のための溶解可能な裏打ち層
JP2007526340A (ja) * 2004-03-03 2007-09-13 ルバンス セラピュティックス ボツリヌストキシンの局所適用及び経皮送達のための組成物及び方法
JP2007527431A (ja) * 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
JP2005306746A (ja) * 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
JP2007538010A (ja) * 2004-05-07 2007-12-27 ファイトトックス リミテッド フィコトキシンの経皮投与
JP2008531732A (ja) * 2005-03-03 2008-08-14 ルバンス セラピュティックス インク． ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法
JP2010514781A (ja) * 2006-12-29 2010-05-06 ルバンス セラピュティックス インク． Ｈｉｖ−ｔａｔに由来するポリペプチド断片を用いて安定化されるボツリヌス毒素を局所適用及び経皮送達する組成物及び方法
JP2013509248A (ja) * 2009-10-30 2013-03-14 ルバンス セラピュティックス インク． 治療組成物又は美容組成物を局所的に塗布する装置及び方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018531984A (ja) * 2015-10-29 2018-11-01 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法

Also Published As

Publication number Publication date
WO2013142755A1 (en) 2013-09-26
KR20140139010A (ko) 2014-12-04
HK1207007A1 (en) 2016-01-22
CA2867511A1 (en) 2013-09-26
US20130251770A1 (en) 2013-09-26
EP2841095A1 (en) 2015-03-04
MX2014011376A (es) 2014-10-14
AU2013234988A1 (en) 2014-10-09
CN104602703A (zh) 2015-05-06
EP3103472A1 (en) 2016-12-14
US20170157020A1 (en) 2017-06-08
EP2841095A4 (en) 2016-01-13
BR112014023244A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
JP6976997B2 (ja) 注射用ボツリヌス毒素製剤
US20170157020A1 (en) Method of treatment of wrinkles using topical chemodenervating agents
EP2413947B1 (en) Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
JP2022008814A (ja) 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法
US20150157728A1 (en) Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
CN101616682A (zh) 用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
US20200179498A1 (en) Methods of treatment for cervical dystonia
CN117279654A (zh) 用于治疗颈肌张力障碍的方法
HK1240854A1 (zh) 可注射的肉毒杆菌毒素制剂
HK1162925A (en) Injectable botulinum toxin formulations
HK40020585A (en) Methods of treatment for cervical dystonia
BRPI1014922B1 (pt) Uso de uma composição tópica, emplastro para pele e kit para tratar o distúrbio da pele
HK40000453A (en) Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160322

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160322

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170328

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20171019